This site is for US healthcare professionals only
Start Exploring
Chronic kidney disease (CKD) is one of the most frequent complications arising from diabetes and is an independent risk factor for cardiovascular (CV) disease. Early diagnosis and management of CKD in patients with type 2 diabetes (T2D) offer the potential to reduce CV events, morbidity, and mortality.
Earlier intervention in your patients with CKD associated with T2D may slow disease progression, thereby protecting the heart and kidneys. We invite you to explore educational resources and information on this website and implement guideline-directed medical treatment in your clinical setting.
You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. For Bayer products, you can report these directly to Bayer by clicking here.
This nonpromotional educational website has been developed and funded by Bayer US Medical Affairs.
